ANDREA GRIFFIN: Open Payments
NPI 1669911087 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 19 payments from 11 companies in 2025. Trend: 2023 $99 · 2024 $15 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 7 | $496 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Boston Scientific Corporation | 1 | $30 |
| Genentech USA, Inc. | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Immunocore Limited | 1 | $21 |
| Verastem, Inc. | 1 | $20 |
| Stryker Corporation | 1 | $20 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $17 |
| Acera Surgical, Inc. | 1 | $17 |
Products named: MIDAS REX, O-ARM, General - Pain Management, Venclexta, PLASMABLADE(TM), KISQALI, KIMMTRAK, TAGRISSO.
Industry payments across SC — which companies pay providers there.
